Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
5.18
+0.64 (14.10%)
At close: Dec 20, 2024, 4:00 PM
5.44
+0.26 (5.02%)
After-hours: Dec 20, 2024, 7:22 PM EST
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $153.38 million as of December 20, 2024.
Market Cap
153.38M
Enterprise Value
152.64M
1-Year Change
n/a
Ranking
Category
Stock Price
$5.18
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $153.38M, a decrease of -26.00%. That is a compound annual growth rate of -29.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 153.38M | -26.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seres Therapeutics | 156.31M |
| Cellectis | 155.56M |
| Sutro Biopharma | 155.02M |
| Adaptimmune Therapeutics | 154.78M |
| The Joint | 153.88M |
| Biomea Fusion | 153.29M |
| Metagenomi | 151.57M |
| Zura Bio | 148.87M |